IL4I1 and cancer: These features of AhR activation and the role of the check-point IL4I1 further emphasise the need to focus future studies on the role of KA in cancer and on strategies aimed at lowering its levels, which are raised in tumours, sera, bone marrow and intestinal mucosal material of patients with cancer types [74].